John Haslam is an accomplished professional in the pharmaceutical and biotechnology industries, currently serving as General Manager at argenx since August 2022 and President of HEARD Consulting International since April 2021. With extensive experience as a Rare Disease Consultant and prior roles including General Manager for both Canada at Horizon and Alexion Pharmaceuticals, John Haslam significantly contributed to the growth of various companies. Earlier career highlights include founding SBP Launch Specialists, leading the Dermatology Business Unit at Biogen Idec, and serving as the Director of Marketing at Hoffmann-La Roche. John Haslam holds an M.B.A. in Marketing from McMaster University and a Bachelor of Science in Microbiology and Immunology from the University of Toronto.
This person is not in any teams
This person is not in any offices